Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Pluristem Therapeutics (PSTI +4.2%) enjoys continued upward momentum after Thursday's news that...

  • Friday, August 17, 2012, 9:34 AM ET
    Pluristem Therapeutics (PSTI +4.2%) enjoys continued upward momentum after Thursday's news that it received permission from India's health ministry to proceed with a Phase II clinical trial for the treatment of Buerger's disease. The trial could be followed by a larger multi-national Phase III. Shares popped 10% yesterday on the announcement.
Track new comments on this story

This news story has 3 comments:

  •  
    Company seems possibly great stock is scary great is it just mo or is something coming soon that warrants this price action with this huge volumes
    17 Aug 2012, 12:37 PM Reply Like
  •  
    I am an aggressive, middle age investor. I live in both Nashville and Israel.

    PSTI is an exciting company with huge possibilities. I totally agree with Scott Matusow that PSTI and ATRS are retirement quality stocks.
    19 Aug 2012, 04:13 PM Reply Like
  •  
    Friday looked like a classic rig job considering volumes and how it traded! Watch out, I sold all my stocks! Way down I'm a buyer if it continues to pick up industry support!
    20 Aug 2012, 09:51 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »